Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$79.8M
5 rounds on record
Latest round
$13.2M
Venture round · Jul 2023 · 3 yr ago
Team
62
US Form 5500 (plan participants) · Dec 2024
Backers
1
Arboretum Ventures
The money's age
Long since its last round
38 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2023 $13.2M — SEC Form D
Venture round Aug 2021 $24M — SEC Form D
Venture round Dec 2019 $22.2M — SEC Form D
Venture round May 2018 $5M — SEC Form D
Venture round Jul 2017 $15.4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity RareCyte, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Ronald SeubertDirectorSEC Form D
Evan CastigliaExecutive OfficerSEC Form D
Joseph VictorExecutive Officer, DirectorSEC Form D
Eric KaldjianExecutive OfficerSEC Form D
Jim CooperExecutive OfficerSEC Form D
Joseph Victor Jr.Executive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Spatial proteomics from H&E. Lattice predicts spatially resolved protein-marker maps from routine H&E, delivered as virtual mIF channels.
VizgenVenture round $47.8M · 8 mo ago • Founded 2019 • 201-500 employees
Explore the future of spatial biology with Vizgen’s multiomics platforms. Uncover cellular insights through spatial transcriptomics and…
SmartCatchFounded 2016
Smartcatch is lifting the current locks on CTC liquid biopsy by developing a range of compact, portable, easy-to-use products that can…
Enumera MolecularVenture round $18.7M · 4 yr ago • Founded 2022 • 51-200 employees
At Enumera Molecular we are transforming the field of complex diagnostic testing to a simpler, cost-effective tool for physicians to…
Watchmaker GenomicsVenture round $40M · 4 yr ago • Founded 2018 • 201-500 employees • 11 roles
Watchmaker Genomics: High-performance NGS library prep and engineered enzymes. Maximize sensitivity and sequencing economy for clinical and…
Plasmidsaurus51-200 employees • 15 roles
Plasmidsaurus is the sequencing infrastructure for modern biology. Founded by scientists, for scientists, it was built around a simple…

Overview

RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid biopsy. Its Orion spatial proteomics platform enables single-round high-plex immunofluorescence imaging for translational and clinical research.

People

Ronald Seubert
Director
Evan Castiglia
Executive Officer
Joseph Victor
Executive Officer, Director
Eric Kaldjian
Executive Officer
Jim Cooper
Executive Officer
Joseph Victor Jr.
Executive Officer, Director
Stephen Reichenbach
Executive Officer
Robert Shepler
Director
Brian Daniels
Director
Frank Witney
Director
Andrew Schwab
Director
David Kabakoff
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Seattle United States
HQ
200-500 est. staff
2601 Fourth Avenue #500, Seattle, WA, 98121, US
company site

Financials

Total raised
$79.8M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $13.2M Details
Venture - Series Unknown 2021 $24M Details
Venture - Series Unknown 2019 $22.2M Details
Venture - Series Unknown 2018 $5M Details
Venture - Series Unknown 2017 $15.4M Details